Financials
Financial year 2025
Worth noting
- Figures corrected afterwards (2022).
Revenue
€ 14.3 million
▲ 5% vs 2024
Profit
Healthy€ 594,317
▼ 33% vs 2024
Debts
Low€ 4.4 million
▲ 1% vs 2024
COCHLEAR BENELUX from Mechelen, company number BE0439545206, closed financial year 2025 with a result of € 594,317 after tax. For that financial year COCHLEAR BENELUX recorded revenue of € 14.3 million and equity of € 5.3 million. Compared with financial year 2024, the result moved from € 883,688 to € 594,317. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 15, 2026.
What happened at COCHLEAR BENELUX?
What happened at COCHLEAR BENELUX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 594,317 (▼ 33% vs 2024). Source: NBB ↗
- Anna Maria Helling stepped down as director. NBB
- Anthony Bishop became a director. NBB
- Sarah Thom became a director. NBB
- Richard Brook stepped down as director. NBB
- Stuart Sayers stepped down as director. NBB
- Anna Maria Helling became a director. NBB
- Stuart Sayers became a director. NBB
In short
From € 727,423 profit in 2022 to € 594,317 profit in 2025.
Paid € 1.4 million in corporate taxes since 2022.
Best year ever: 2023, with € 890,835 profit.
Pays suppliers within 51 days on average.
A new publication or filing at COCHLEAR BENELUX? We notify you, reason included.
Follow COCHLEAR BENELUXNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind COCHLEAR BENELUX are Anthony Bishop and Sarah Thom. The shares are held by COCHLEAR EUROPE LTD (99%) and COCHLEAR LIMITED (1%).
Directors
According to the 2025 annual accounts
Anthony Bishop
Director
since 2025
Sarah Thom
Director
since 2025
Richard Brook
Director
since 2021 · until 2024
Stuart Sayers
Director
since 2021 · until 2024
Anna Maria Helling
Director
since 2021 · until 2025
Shareholders
COCHLEAR EUROPE LTD
99%
COCHLEAR LIMITED
1%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Schaliënhoevedreef 20 box I
2800 Mechelen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 58 companies are registered at this address.
PLANON
€ 10.4 million revenue · 2025
DRIVE SYSTEMS
€ 6.6 million gross margin · 2025
BOREALIS FINANCIAL SERVICES
€ 1.4 million revenue · 2025
CBR Fashion Belgium
€ 2.7 million gross margin · 2025
BAS DISTRIBUTION
+53 more
Details
- Company number
- 0439.545.206
- VAT number
- BE 0439.545.206
- Registered office
- Schaliënhoevedreef 20 bus I, 2800 Mechelen
- Names & denominations
- COCHLEAR BENELUX
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 19 January 1990
- Peppol
- Active · Active since 20 Nov 2020
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Groothandel in overige intermediaire producten, n.e.g.
Handelsbemiddeling in de groothandel in andere specifieke goederen
Groothandel in andere intermediaire producten, neg
Groothandel in andere intermediaire producten, n.e.g.